The D Domain of LRRC4 anchors ERK1/2 in the cytoplasm and competitively inhibits MEK/ERK activation in glioma cells

BACKGROUND: As a well-characterized key player in various signal transduction networks, extracellular-signal-regulated kinase (ERK1/2) has been widely implicated in the development of many malignancies. We previously found that Leucine-rich repeat containing 4 (LRRC4) was a tumor suppressor and a ne...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:J Hematol Oncol
Päätekijät: Wang, Zeyou, Guo, Qin, Wang, Rong, Xu, Gang, Li, Peiyao, Sun, Yingnan, She, Xiaoling, Liu, Qiang, Chen, Qiong, Yu, Zhibin, Liu, Changhong, Xiong, Jing, Li, Guiyuan, Wu, Minghua
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: BioMed Central 2016
Aiheet:
Research
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC5123285/
https://ncbi.nlm.nih.gov/pubmed/27884160
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13045-016-0355-1
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia